FDA Inspection
Summit Biosciences Inc.Summit Biosciences Inc. – FDA Inspection, Feb 21, 2025
Record Details
This FDA Inspection record concerns Summit Biosciences Inc., with an inspection on February 21, 2025, issued by the Cincinnati District Office, covering human drugs.
View Company Profile
ID · fbf78c84-7d7e-4694-9f67-ee101159342d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1261583
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.110(a)Written in-process control procedures
- FDCA 582(b)(4)Systems in place to comply with verification requirements
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Summit Biosciences Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 14, 2023 | NAI | Compliance: Devices | |
| February 4, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 23, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 18, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 28, 2014 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
Other documents for Summit Biosciences Inc.
- FDA Inspection 1218227 - 2023-09-14
- FDA Inspection 1121348 - 2020-02-04
- FDA Inspection 1018004 - 2017-06-23
- FDA Inspection 933643 - 2015-06-18
- FDA Inspection 868633 - 2014-02-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.